Adaptive Biotechnologies

Adaptive Biotechnologies translates a scale and precision of the adaptive immune system into products to diagnose and treat disease.

The company brings accuracy and sensitivity of our immunosequencing platform into laboratories around the world to drive groundbreaking research in cancer and other immune-mediated diseases. We are also committed to translating immunosequencing discoveries into clinical diagnostics and therapeutic development to improve patient care.

Founders: Chad Robins, Christopher Carlson, Harlan Robins